Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00272324 · ClinicalTrials.gov registry record · Phase 2
Aspirin/Folate Prevention of Large Bowel Polyps
A Phase 2 study, sponsored by Dartmouth-Hitchcock Medical Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 1,121
- Enrollment target
NCT00272324 is a Phase 2 study that has completed, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 1,121 participants.
The verdict
NCT00272324, a Phase 2 study, has completed, sponsored by Dartmouth-Hitchcock Medical Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 1,121 participants
- Enrollment target
Study Summary
This is a randomized controlled trial of aspirin and/or folate supplementation for the prevention of the recurrence of neoplastic polyps (adenomas) of the large bowel.
Interventions
- DRUG Aspirin
- DRUG Folate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,121 participants |
| Start Date | 1992-02 |
| Est. Completion | 2007-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00272324
The ClinicalTrials.gov registry entry for NCT00272324 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 1,121 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dartmouth-Hitchcock Medical Center, which has 427 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Aspirin is the first listed.
NCT00272324 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00272324 about?
NCT00272324 is a clinical study titled "Aspirin/Folate Prevention of Large Bowel Polyps". This is a randomized controlled trial of aspirin and/or folate supplementation for the prevention of the recurrence of neoplastic polyps (adenomas) of the large bowel.
What is the current status of trial NCT00272324?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 1,121 participants. The study started on 1992-02. Estimated completion is 2007-01.
What interventions are being tested in trial NCT00272324?
The interventions under investigation include: Aspirin (DRUG), Folate (DRUG).
Who is sponsoring clinical trial NCT00272324?
This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.